<bill session="115" type="h" number="6071" updated="2019-07-16T21:20:08Z">
  <state datetime="2018-06-12">REFERRED</state>
  <status>
    <introduced datetime="2018-06-12"/>
  </status>
  <introduced datetime="2018-06-12"/>
  <titles>
    <title type="official" as="introduced">To amend the Public Health Service Act to clarify the intent of the 340B program and provide for enhanced 340B program integrity, and for other purposes.</title>
    <title type="short" as="introduced">SERV Communities Act</title>
    <title type="short" as="introduced">SERV Communities Act</title>
    <title type="short" as="introduced">Stretching Entity Resources for Vulnerable Communities Act</title>
    <title type="short" as="introduced">Stretching Entity Resources for Vulnerable Communities Act</title>
    <title type="display">SERV Communities Act</title>
  </titles>
  <sponsor bioguide_id="M001163"/>
  <cosponsors>
    <cosponsor bioguide_id="C001037" joined="2018-07-12"/>
    <cosponsor bioguide_id="C001080" joined="2018-07-10"/>
    <cosponsor bioguide_id="C001038" joined="2018-07-23"/>
    <cosponsor bioguide_id="D000617" joined="2018-10-23"/>
    <cosponsor bioguide_id="D000623" joined="2018-07-06"/>
    <cosponsor bioguide_id="G000559" joined="2018-07-12"/>
    <cosponsor bioguide_id="H001038" joined="2018-10-12"/>
    <cosponsor bioguide_id="K000379" joined="2018-07-06"/>
    <cosponsor bioguide_id="L000397" joined="2018-07-13"/>
    <cosponsor bioguide_id="L000562" joined="2018-07-16"/>
    <cosponsor bioguide_id="M001185" joined="2018-07-19"/>
    <cosponsor bioguide_id="M000312" joined="2018-07-12"/>
    <cosponsor bioguide_id="M001196" joined="2018-07-24"/>
    <cosponsor bioguide_id="N000127" joined="2018-07-24"/>
    <cosponsor bioguide_id="N000147" joined="2018-12-11"/>
    <cosponsor bioguide_id="P000604" joined="2018-09-25"/>
    <cosponsor bioguide_id="P000258" joined="2018-07-16"/>
    <cosponsor bioguide_id="P000607" joined="2018-07-16"/>
    <cosponsor bioguide_id="R000606" joined="2018-07-23"/>
    <cosponsor bioguide_id="R000486" joined="2018-11-09"/>
    <cosponsor bioguide_id="R000515" joined="2018-08-03"/>
    <cosponsor bioguide_id="S001150" joined="2018-07-10"/>
    <cosponsor bioguide_id="S001196" joined="2018-07-24"/>
    <cosponsor bioguide_id="V000081" joined="2018-07-19"/>
    <cosponsor bioguide_id="V000108" joined="2018-07-25"/>
    <cosponsor bioguide_id="W000800" joined="2018-07-27"/>
  </cosponsors>
  <actions>
    <action datetime="2018-06-12">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-06-12" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-06-12">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-06-14">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="4392"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-12T04:00:00Z" status="Introduced in House">Stretching Entity Resources for Vulnerable Communities Act or the SERV Communities Act

This bill makes a series of changes to the 340B drug pricing program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers), including alterations relating to program integrity, discrimination against participating entities, and program eligibility.</summary>
  <committee-reports/>
</bill>
